Price Alert

ResMed Inc. (RMD)

NYSE: RMD · Real-Time Price · USD

284.69

-3.59 (-1.25%)

At close: Aug 14, 2025, 3:59 PM

285.00

0.11%

Pre-market: Aug 15, 2025, 07:05 AM EDT

ResMed Statistics

Share Statistics

ResMed has 146.63M shares outstanding. The number of shares has increased by -0.21% in one year.

Shares Outstanding	146.63M
Shares Change (YoY)	-0.21%
Shares Change (QoQ)	-0.16%
Owned by Institutions (%)	63.48%
Shares Floating	145.87M
Failed to Deliver (FTD) Shares	152
FTD / Avg. Volume	0.02%

Short Selling Information

The latest short interest is 9.38M, so 6.4% of the outstanding shares have been sold short.

Short Interest	9.38M
Short % of Shares Out	6.4%
Short % of Float	7.36%
Short Ratio (days to cover)	13.09

Valuation Ratios

The PE ratio is 27.02 and the forward PE ratio is 25.9. ResMed's PEG ratio is 0.72.

PE Ratio	27.02
Forward PE	25.9
PS Ratio	7.36
Forward PS	7.4
PB Ratio	6.34
P/FCF Ratio	22.78
PEG Ratio	0.72

Financial Ratio History

Enterprise Valuation

ResMed has an Enterprise Value (EV) of 37.5B.

EV / Sales	7.29
EV / EBITDA	19.6
EV / EBIT	21.41
EV / FCF	22.56

Financial Position

The company has a current ratio of 3.44, with a Debt / Equity ratio of 0.14.

Current Ratio	3.44
Quick Ratio	2.53
Debt / Equity	0.14
Debt / EBITDA	0.45
Debt / FCF	0.51
Interest Coverage	0

Financial Efficiency

Return on Equity is 23.47% and Return on Invested Capital is 19.58%.

Return on Equity	23.47%
Return on Assets	17.14%
Return on Invested Capital	19.58%
Revenue Per Employee	$515.66K
Profits Per Employee	$140.35K
Employee Count	9,980
Asset Turnover	0.63
Inventory Turnover	2.25

Taxes

Income Tax	276.84M
Effective Tax Rate	16.5%

Stock Price Statistics

The stock price has increased by 32.51% in the last 52 weeks. The beta is 0.77, so ResMed's price volatility has been higher than the market average.

Beta	0.77
52-Week Price Change	32.51%
50-Day Moving Average	260.2
200-Day Moving Average	241.76
Relative Strength Index (RSI)	65.05
Average Volume (20 Days)	937,946

Income Statement

In the last 12 months, ResMed had revenue of 5.15B and earned 1.4B in profits. Earnings per share was 9.55.

Revenue	5.15B
Gross Profit	3.05B
Operating Income	1.69B
Net Income	1.4B
EBITDA	1.91B
EBIT	1.68B
Earnings Per Share (EPS)	9.55

Full Income Statement

Balance Sheet

The company has 1.21B in cash and 851.81M in debt, giving a net cash position of 357.64M.

Cash & Cash Equivalents	1.21B
Total Debt	851.81M
Net Cash	357.64M
Retained Earnings	6.08B
Total Assets	8.17B
Working Capital	2.49B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.75B and capital expenditures -89.86M, giving a free cash flow of 1.66B.

Operating Cash Flow	1.75B
Capital Expenditures	-89.86M
Free Cash Flow	1.66B
FCF Per Share	11.33

Full Cash Flow Statement

Margins

Gross margin is 59.36%, with operating and profit margins of 32.79% and 27.22%.

Gross Margin	59.36%
Operating Margin	32.79%
Pretax Margin	32.6%
Profit Margin	27.22%
EBITDA Margin	37.18%
EBIT Margin	32.79%
FCF Margin	32.29%

Dividends & Yields

RMD pays an annual dividend of $2.72, which amounts to a dividend yield of 0.77%.

Dividend Per Share	$2.72
Dividend Yield	0.77%
Dividend Growth (YoY)	10.42%
Payout Ratio	28.6%
Earnings Yield	3.7%
FCF Yield	4.39%

Dividend Details

Analyst Forecast

The average price target for RMD is $290, which is 2% higher than the current price. The consensus rating is "Buy".

Price Target	$290
Price Target Difference	2%
Analyst Consensus	Buy
Analyst Count	12

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$228.34
Lynch Upside	-19.72%
Graham Number	93.48
Graham Upside	-67.13%

Stock Splits

The last stock split was on Aug 31, 2010. It was a forward split with a ratio of 2:1.

Last Split Date	Aug 31, 2010
Split Type	forward
Split Ratio	2:1

Scores

Altman Z-Score	14.04
Piotroski F-Score	9